- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
External Dynamics Contextualizing the FDA’s Role in E-Cigarette Regulation
American Journal of Bioethics 22 (10):32-34 (2022)
Abstract
The authors of the target article articulate the complicated, often conflicting demands of U.S. Food and Drug Administration roles as justification for the FDA’s delay in releasing guidelines...My notes
Similar books and articles
Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.Liam Bendicksen & Aaron S. Kesselheim - 2023 - Journal of Law, Medicine and Ethics 51 (2):448-449.
Fresh Take: Pitfalls of the FDA’s Proposed Menthol Ban.Amirala Pasha & Richard Silbert - 2022 - Journal of Law, Medicine and Ethics 50 (1):60-66.
Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products.Joshua M. Sharfstein, James Dabney Miller, Anna L. Davis, Joseph S. Ross, Margaret E. McCarthy, Brian Smith, Anam Chaudhry, G. Caleb Alexander & Aaron S. Kesselheim - 2017 - Journal of Law, Medicine and Ethics 45 (s2):7-23.
The U.S. Food and Drug Administration's Evaluation of the Safety of Animal Clones: A Failure to Recognize the Normativity of Risk Assessment Projects.Inmaculada de Melo-Martín & Zahra Meghani - 2009 - Bulletin of Science, Technology and Society 29 (1):9-17.
Limitations on the Capability of the FDA to Advise.Aaron S. Kesselheim & Leah Z. Rand - 2022 - American Journal of Bioethics 22 (10):15-17.
Mifepristone Paternalism at the FDA.Jordan Paradise - 2023 - Journal of Law, Medicine and Ethics 51 (3):554-559.
Marketing off-label uses to physicians: Fda's draft (mis)guidance.Andy Gass & Jennifer Wilson - 2008 - American Journal of Bioethics 8 (3):1 – 3.
Withholding Information on Unapproved Drug Marketing Applications: The Public Has a Right to Know.Sammy Almashat & Michael Carome - 2017 - Journal of Law, Medicine and Ethics 45 (s2):46-49.
Aducanumab, Accelerated Approvals & the Agency: Why the FDA Needs Structural Reform.Matthew Herder - 2023 - Journal of Law, Medicine and Ethics 51 (4):900-919.
E-Cigarette Use and Regulation: A Comparative Analysis between the United States, the UK, and China.Fengmin Shao, Yue Gu, Lijun Shen, Yuming Wang & Hui Zhang - 2022 - American Journal of Bioethics 22 (10):29-31.
Analytics
Added to PP
2022-09-28
Downloads
20 (#792,293)
6 months
14 (#200,423)
2022-09-28
Downloads
20 (#792,293)
6 months
14 (#200,423)
Historical graph of downloads
Citations of this work
E-Cigarettes, the FDA, Public Health, and Harm Reduction: A Response to the Open Peer Commentaries.Larisa Svirsky, Dana Howard & Micah L. Berman - 2022 - American Journal of Bioethics 23 (1):1-4.
References found in this work
E-Cigarettes and the Multiple Responsibilities of the FDA.Larisa Svirsky, Dana Howard & Micah L. Berman - 2021 - American Journal of Bioethics 22 (10):5-14.
Psychological Pathways Linking Public Trust During the Coronavirus Pandemic to Mental and Physical Well-being.Ayokunle A. Olagoke, Olakanmi O. Olagoke & Ashley M. Hughes - 2020 - Frontiers in Psychology 11.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-68866f4b87-sz9d2 uwo